Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Summer;16(3):140-146.
doi: 10.34172/joddd.2022.024. Epub 2022 Nov 15.

Clinicopathological and prognostic value of Ki-67 expression in oral malignant melanoma: A systematic review and meta-analysis

Affiliations
Review

Clinicopathological and prognostic value of Ki-67 expression in oral malignant melanoma: A systematic review and meta-analysis

Mohammad Hossein Moltajaei et al. J Dent Res Dent Clin Dent Prospects. 2022 Summer.

Abstract

Background. Ki-67 is one of the new biological markers with clinical value in the pathology and prognosis of oral melanoma. It is a nuclear protein involved in regulating cell proliferation. Some studies have suggested an association between Ki-67 and poor survival in patients with oral melanoma. This systematic review was undertaken to clarify this issue. Methods. Databases of PubMed, Scopus, and Web of Science were searched using relevant English keywords from 1988 to April 2022. STATA software version 16 and random models were used for meta-analysis. Results. Eleven articles were included in this systematic review, six of which were selected for meta-analysis. The mean expression of the Ki-67 index in patients with oral melanoma was estimated at 43.81% (28.66‒58.95 with 95% CI, I2=94.2, P<0.001). In addition, the results showed a significant relationship between Ki-67 expression and the prognosis of oral melanoma lesions. Increased expression of this marker weakens the prognosis and decreases the survival rate. Conclusion. High expression of Ki-67 may serve as a predictive biomarker for poor prognosis in patients with malignant oral melanoma. Therefore, classifying this malignancy by Ki-67 expression may be considered for therapy regimen selection and integrated management.

Keywords: Ki-67; Meta-analysis; Oral malignant melanoma; Prognosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Figure 2
Figure 2
Figure 3
Figure 3

Similar articles

Cited by

References

    1. Alaeddini M, Etemad-Moghadam S. Immunohistochemical profile of oral mucosal and head and neck cutaneous melanoma. J Oral Pathol Med. 2015;44(3):234–8. doi: 10.1111/jop.12235. - DOI - PubMed
    1. Golger A, Young DS, Ghazarian D, Neligan PC. Epidemiological features and prognostic factors of cutaneous head and neck melanoma: a population-based study. Arch Otolaryngol Head Neck Surg. 2007;133(5):442–7. doi: 10.1001/archotol.133.5.442. - DOI - PubMed
    1. de Andrade BA, León JE, Carlos R, Delgado-Azañero W, Mosqueda-Taylor A, de Almeida OP. Expression of minichromosome maintenance 2, Ki-67, and geminin in oral nevi and melanoma. Ann Diagn Pathol. 2013;17(1):32–6. doi: 10.1016/j.anndiagpath.2012.05.001. - DOI - PubMed
    1. Rodrigues BT, Cunha JL, Albuquerque DM, Chagas WP, Freire ND, Agostini M, et al. Primary melanoma of the oral cavity: a multi-institutional retrospective analysis in Brazil. Med Oral Patol Oral Cir Bucal. 2021;26(3):e379–e86. doi: 10.4317/medoral.24240. - DOI - PMC - PubMed
    1. Meleti M, Leemans CR, Mooi WJ, Vescovi P, van der Waal I. Oral malignant melanoma: a review of the literature. Oral Oncol. 2007;43(2):116–21. doi: 10.1016/j.oraloncology.2006.04.001. - DOI - PubMed

LinkOut - more resources